Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...
While treatments for cancer and heart disease have advanced in leaps and bounds, psychiatry continues to use the drugs that ...
If depression isn’t just a chemical imbalance, what drives it? A psychiatrist unpacks the latest research, why SSRIs still ...
Later, Eli Lilly & Co introduced the bestselling SSRI drug, Prozac ... this time to develop small-molecule protein kinase B (PKB) to further contribute in the fight against cancer.
A new study suggests that fluoxetine, commonly known as Prozac, may do more than treat depression. Researchers at the Salk ...
For chronic, longer-term issues, people turn to exercise, spinal manipulation, taping, antidepressants, and drugs that turn on the TRPV receptor — a cell “keyhole” that, when activated, has shown ...
CHATHAM, N.J., March 18, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and ...
This article reviews the contribution of recent preclinical, clinical and pharmacogenetic literature to current knowledge on the short-term and enduring neural effects of antidepressants on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results